Recent news on Lysodren

HRA Pharma commences UK-based Phase III trial of Ella, a second ...  -  27 Mar 2007
PharmaLive.com (press release),...and Lysodren ®, for the treatment of adrenal cortical carcinoma. Three of HRA's products have received national awards for their usefulness to patients.

HRA Pharma Commences US Phase III Trial of Second-Generation ...  -  26 Dec 2006
PharmaLive.com (press release),Mona-Lisa(R), a copper contraceptive IUD (intrauterine device), and Lysodren(R), for the treatment of adrenal cortical carcinoma.

HRA Pharma Commences US Phase III Trial of Second-Generation ...  -  Dec 7, 2006
Business Wire (press release),Mona-Lisa ® , a copper contraceptive IUD (intrauterine device), and Lysodren ® , for the treatment of adrenal cortical carcinoma.

HRA Pharma Commences US Phase III Trial of Second-Generation ...  -  Dec 7, 2006
PharmaLive.com (press release),Mona-Lisa(R), a copper contraceptive IUD (intrauterine device), and Lysodren(R), for the treatment of adrenal cortical carcinoma.

HRA Pharma Commences US Phase III Trial of Second-Generation ...  -  Dec 7, 2006
Business Wire (press release),Mona-Lisa ® , a copper contraceptive IUD (intrauterine device), and Lysodren ® , for the treatment of adrenal cortical carcinoma.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional